Privacy Policy
Signals Blog

Contributors

Categories

True Blood: An enterprise in engineering

  True synthetic blood is coming, but it won’t be packaged like this. We’ve all heard the idiom “it’s in my blood”. For me, this applies to hockey and rock climbing. And a quick survey of my class suggests that everything from Southern BBQ sauce and ice...

“The process must go on”: ISSCR 2013

. The sheer scale of ISSCR 2013, which has attracted almost four thousand delegates, and the proficiency with which it is run, is a major achievement by its organizer and lead sponsor: the International Society for Stem Cell Research and the Harvard Stem Cell...

Overcoming the “blood-clinic barrier”: ISSCR 2013

. Irrespective of scientific discipline, everyone is aware of the blood-brain barrier. Since its proposal in 1900 by Max Lewandowsky, and later confirmation of its discovery in the 1960s – facilitated by the advancement of the scanning electron microscope – it has...

Right Turn: Primer on MSCs in clinical trials

. In this podcast titled “Opportunities and Challenges in Developing Innovative Stem Cell Therapies,” Dr. Armand Keating focuses specifically on the commercialization of mesenchymal stem cells (stromal cells). He has established the largest stem cell transplant...